InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: Jimmy Joe post# 149229

Saturday, 03/28/2015 9:44:30 PM

Saturday, March 28, 2015 9:44:30 PM

Post# of 400571
'Jimmy Joe' There is much more to the story about Purdue "dissing" $ELTP, but Professional ethics doesn't allow it to be said.

As I have said "What goes around comes around" is a most fitting situation as now the positions are reversed. It will be most interesting what $ELTP's law firm Baker and Hostetler are advising $ELTP as to their 1st ADT agonist best action.

Litigation and Revenues in that order will be what B&H are advising $ELTP and all Professional "eyes" are watching for the next clue. That clue may or may not be in the details of $ELTP's P3 Clinical Trial for pain efficacy. Either $ELTP wording clarifies the agonist or $ELTP continues with their cloak of confidentiality.

The saga continues so keep watching the website

https://clinicaltrials.gov/

Always enter the key search wording for the latest $ELTP entries.

"Elite Laboratories, Inc"

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News